Genome editing is a completely new technology first used in trials in 2009.  CRISPR technology, developed in 2012, has significantly increased its clinical potential. Dr Alasdair Russell is the head of CRUK CI’s Genome Editing facility.  See the CRUK CI’s Genome Editing homepage for more information.